Last updated on June 2020

JUNIPER: A Phase 2 Study to Evaluate the Safety Biological Activity and PK of ND-L02-s0201 in Subjects With IPF

Brief description of study

A phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, tolerability, biological activity, and pharmacokinetics (PK) of ND-L02-s0201 for Injection in subjects with IPF.

Clinical Study Identifier: NCT03538301

Find a site near you

Start Over

Emory University

Atlanta, GA United States
  Connect »

Cedars-Sinai Medical Center

Los Angeles, CA United States
  Connect »

Mayo Clinic Florida

Jacksonville, FL United States
  Connect »

Norton Clinical Research Group

Louisville, KY United States
  Connect »

Duke University Hospital

Durham, NC United States
  Connect »

University of Utah Health

Salt Lake City, UT United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.